Alzheimer’s disease is a debilitating condition that affects memory and cognitive function, leading to dementia in advanced stages. Early detection is crucial for effective treatment and lifestyle changes to slow the progression of the disease.
Prof. David Tana, a neurology expert, emphasizes the importance of early detection in guiding drug treatment and lifestyle modifications to delay disease progression. Alzheimer’s is the leading cause of dementia among older adults, with a significant number of cases in Israel and projected to triple by 2050.
A new test has been developed to identify protein deposits called amyloid in the blood, which accumulate in the brain and cause nerve cell damage. This test can accurately diagnose Alzheimer’s at an early stage, allowing for timely intervention and management of the condition. The test is available for individuals over 18 who have been referred by a doctor for cognitive testing. The cost of the amyloid test is NIS 3,450 and can be combined with additional tests for specific drug treatment or genetic prediction of the disease. Most private health insurances in Israel now cover the test, and it is expected to be subsidized by health funds soon.
The website offers various resources and links on topics ranging from wedding planning to event workshops to cooking recipes, providing a diverse range of content for different interests and needs. Users can also explore writing services, web hosting, and sports forums on the website, making it a valuable resource for individuals seeking information on various topics.